OS

Niio, the World's Leading Platform for Digital Art Engagement, Announces $15M A-Round and Strategic Partnership with Samsung Displays

Tuesday, September 21, 2021 - 3:08pm

Niio will use its capital to grow its artist community and scale its app-enabled subscription and purchase platform, which is blockchain based and will include a trading-enabled marketplace for NFTs and other digital art assets.

Key Points: 
  • Niio will use its capital to grow its artist community and scale its app-enabled subscription and purchase platform, which is blockchain based and will include a trading-enabled marketplace for NFTs and other digital art assets.
  • "This partnership with Niio will allow users to transform their spaces with stunning, versatile digital canvases that display the very best in digital art."
  • We thank them for their confidence, and we are similarly honored that Samsung has chosen us as their digital art partner."
  • Niio is the world's most complete and open digital art ecosystem which includes NFTs all curated and display-ready through the Niio app.

HealthMyne's Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses

Tuesday, September 21, 2021 - 1:20pm

In the Cancers article, researchers led by Vincenza Granata evaluated HealthMyne's technology as a quantitative imaging decision support tool for radiomic analysis of lung adenocarcinoma in chest CT scans.

Key Points: 
  • In the Cancers article, researchers led by Vincenza Granata evaluated HealthMyne's technology as a quantitative imaging decision support tool for radiomic analysis of lung adenocarcinoma in chest CT scans.
  • Researchers analyzed radiomic biomarkers to predict Overall Survival (OS) and Progression Free Survival (PFS) time.
  • Researchers found that 19 radiomic features were significant for predicting OS and 108 radiomic features for predicting PFS time.
  • At HealthMyne, we strive to develop innovative radiomic solutions that contribute to the advancement of this critical body of evidence."

Park Place Technologies Offers Strengthened Professional Services Portfolio

Tuesday, September 21, 2021 - 1:00pm

Park Place Professional Services delivers value-added services that complement Park Place's core hardware maintenance business.  Professional Services works with clients to innovate technical solutions to IT challenges. These challenges can be centralized in a data center or distributed across the customer's IT infrastructure. As the global leader in data center maintenance, Park Place understands the client's entire IT infrastructure; adding Professional Services further simplifies "one-stop shop" access to data center needs -- saving time and money while protecting Uptime.

Key Points: 
  • Park Place Professional Services delivers value-added services that complement Park Place's core hardware maintenance business.
  • While Park Place previously offered several Professional Services offerings as part of its client experience portfolio, the Curvature acquisition greatly expands the depth and breadth of available services.
  • Hal Malstrom, Park Place GM of Professional Services, said the integration of Curvature's Professional Services strengths further distances Park Place from competitors.
  • Park Place's industry-leading and award-winning services include hardware maintenance, ParkView Managed Services, Entuity software, Curvature Hardware sales, and bespoke Professional Services.

Park Place Technologies Offers Strengthened Professional Services Portfolio

Tuesday, September 21, 2021 - 1:00pm

Park Place Professional Services delivers value-added services that complement Park Place's core hardware maintenance business.  Professional Services works with clients to innovate technical solutions to IT challenges. These challenges can be centralized in a data center or distributed across the customer's IT infrastructure. As the global leader in data center maintenance, Park Place understands the client's entire IT infrastructure; adding Professional Services further simplifies "one-stop shop" access to data center needs -- saving time and money while protecting Uptime.

Key Points: 
  • Park Place Professional Services delivers value-added services that complement Park Place's core hardware maintenance business.
  • While Park Place previously offered several Professional Services offerings as part of its client experience portfolio, the Curvature acquisition greatly expands the depth and breadth of available services.
  • Hal Malstrom, Park Place GM of Professional Services, said the integration of Curvature's Professional Services strengths further distances Park Place from competitors.
  • Park Place's industry-leading and award-winning services include hardware maintenance, ParkView Managed Services, Entuity software, Curvature Hardware sales, and bespoke Professional Services.

Turquoise Plato Connects to OpenFin to Simplify Complexity on the Buy-Side Trader Desktop

Tuesday, September 21, 2021 - 8:00am

Turquoise on OpenFin delivers an insightful data feed directly into trader workflows to support liquidity discovery and decision making processes leveraging OpenFins open architecture.

Key Points: 
  • Turquoise on OpenFin delivers an insightful data feed directly into trader workflows to support liquidity discovery and decision making processes leveraging OpenFins open architecture.
  • We are delighted Turquoise and Turquoise Europe are the first trading venues to connect to OpenFin and offer this new functionality to the buy-side.
  • OpenFin provides a common web-based OS layer across the financial services industry to power next-generation applications and desktop experiences.
  • FlexTrade Systems will be the first to deliver the Turquoise data feed into their flagship EMS via the OpenFin message bus.

Roku Introduces All-New Roku Streaming Stick 4K and Roku Streaming Stick 4K+

Monday, September 20, 2021 - 2:00pm

Roku, Inc. (NASDAQ: ROKU) today unveiled the all-new Roku Streaming Stick 4K (MSRP $49.99), offering powerful 4K streaming in a portable form factor and the Roku Streaming Stick 4K+ (MSRP $69.99), which features the Roku Voice Remote Pro for users looking to upgrade their streaming experience with a rechargeable, hands-free voice remote.

Key Points: 
  • Roku, Inc. (NASDAQ: ROKU) today unveiled the all-new Roku Streaming Stick 4K (MSRP $49.99), offering powerful 4K streaming in a portable form factor and the Roku Streaming Stick 4K+ (MSRP $69.99), which features the Roku Voice Remote Pro for users looking to upgrade their streaming experience with a rechargeable, hands-free voice remote.
  • View the full release here: https://www.businesswire.com/news/home/20210920005185/en/
    Roku Streaming Stick 4K (Photo: Business Wire)
    The Roku Streaming Stick has been a fan favorite for years and weve redesigned it in the Roku Streaming Stick 4K to be faster and more powerful than ever, said Mark Ely, Vice President, Retail Product Strategy at Roku.
  • The Roku Streaming Stick 4K+ ($69.99) is an all-new product that bundles the Roku Streaming Stick 4K described above with the Roku Voice Remote Pro.
  • These statements include but are not limited to the benefits, impact, features, pricing and availability of the new Roku streaming lineup, including the new Roku Streaming Stick 4K+ and Roku Ultra LT, and the features, benefits and reach of the Roku OS and the Roku platform.

Roku OS 10.5 Offers Easy Access to Content, Roku Voice Help, New Mobile Features and Expanded Surround Sound Capabilities

Monday, September 20, 2021 - 2:00pm

Roku, Inc. (NASDAQ: ROKU) today announced Roku OS 10.5 will begin rolling out to Roku devices in the coming weeks.

Key Points: 
  • Roku, Inc. (NASDAQ: ROKU) today announced Roku OS 10.5 will begin rolling out to Roku devices in the coming weeks.
  • Roku OS 10.5 introduces new features putting Live TV front and center for streaming player users, tips on how to get the most out of Roku Voice, new surround sound configurations for audio device owners, more voice control options and updates to Roku mobile app features.
  • With Roku OS 10.5, consumers who want to use their voice can now access new features and ways to get to content quickly.
  • Roku Voice Roku has been expanding the number of channels that support voice commands for direct to playback.

BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncolo

Monday, September 20, 2021 - 12:30pm

ET today at the ESMO Congress in Paris, and the Company will host a conference call at 10:00 a.m.

Key Points: 
  • ET today at the ESMO Congress in Paris, and the Company will host a conference call at 10:00 a.m.
  • This includes the final intention-to-treat (ITT) dataset from the Companys DUBLIN-3 Phase 3 registrational trial of its first-in-class lead asset, plinabulin, in combination with docetaxel vs. docetaxel alone for the treatment of 2nd/3rd line non-small cell lung cancer (NSCLC) patients with EGFR wild type.
  • Plinabulin is a selective immunomodulating microtubule-binding agent (SIMBA), which is a potent antigen presenting cell (APC) inducer.
  • The DUBLIN-3 Phase 3 trial is a randomized, active controlled, single blind to patients, global trial that enrolled 559 patients in 2nd and 3rd line NSCLC, EGFR wild type, with a measurable lung lesion.

ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC

Sunday, September 19, 2021 - 4:30pm

The 12-month probability of survival was 66% for the Libtayo combination and 56% for chemotherapy.

Key Points: 
  • The 12-month probability of survival was 66% for the Libtayo combination and 56% for chemotherapy.
  • The 12-month probability of PFS was 38% for the Libtayo combination and 16% for chemotherapy.
  • The Libtayo combination also improved pain symptoms, compared to chemotherapy (-4.98 difference in baseline changes between treatment groups; 95% CI: -8.36 to -1.60; nominal p=0.004).
  • Treatment discontinuation due to AEs occurred in 5% of patients receiving the Libtayo combination and 3% receiving chemotherapy.

IMFINZI plus chemotherapy tripled patient survival at three years in the CASPIAN Phase III trial in extensive-stage small cell lung cancer

Saturday, September 18, 2021 - 4:30pm

Susan Galbraith, Executive Vice President, Oncology R&D, said: This remarkable improvement in survival is an unprecedented achievement at three years for patients with extensive-stage small cell lung cancer.

Key Points: 
  • Susan Galbraith, Executive Vice President, Oncology R&D, said: This remarkable improvement in survival is an unprecedented achievement at three years for patients with extensive-stage small cell lung cancer.
  • IMFINZI plus chemotherapy continued to demonstrate a well-tolerated safety profile consistent with the known profiles of these medicines.
  • Results showed 32.5% of patients experienced a serious adverse event (all causality) with IMFINZI plus chemotherapy versus 36.5% with chemotherapy alone.
  • In June 2019, AstraZeneca announced the CASPIAN Phase III trial had met one primary endpoint of demonstrating OS for IMFINZI plus chemotherapy at a planned interim analysis.